21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been ... weight-loss medications more than doubled between 2022 and 2023. Meanwhile, they have also been found to ...

A newly developed weight loss pill ... have a new way to help people get healthy again.” Currently, only people involved in a controlled clinical trial are eligible to use Elcella capsules as a way to ...

Lilly answered with Mounjaro and Zepbound, approved in 2022 and 2023 for diabetes ... ‘Novo Nordisk is going to have a new drug [where] 40% of people will get 25% weight loss, but that’ll ...

18 (UPI) --Merck announced a weight loss drug deal Wednesday with ... regulatory and commercial milestones. Advertisement The drug is experimental and works by targeting a gut hormone called ...

Novo Nordisk said it plans to start a new trial in the first half of next year to further explore CagriSema's additional weight-loss potential ... antipsychotic drug August 5, 2022 Future of ...

Compounded by the equally sudden banning of the weight loss drug, phen-fen (phentermine-fenfluramine ... there remained no new promising pharmaceutical agents addressing obesity.

Discover the top stocks for the new year selected by Needham analysts, including ACV Auctions, Alcon, Alegro Microsystems, ...

Elon Musk, the CEO of Tesla and SpaceX, has revealed in a festive post that he's taking a weight loss drug similar to Ozempic ... as he wows with striking new look Among the popular GLP-1 ...

Jessica Simpson showed off a new look ... to diet pills in order to drop to 103 pounds. She would continue to pop diet pills for "the next twenty years," she revealed in the book. In 2022, she ...

Before 2023, between 2013-2022 ... but weight loss drugs like Ozempic are likely a leading factor. Other contributing factors may include better access to healthcare and new food and drug ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...